Clinical Trial Update: A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing Tarceva plus Avastin versus Avastin alone in metastatic renal cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Avastin (bevacizumab)
• Tarceva (erlotinib)

Snippet

Sponsor: Genentech, Inc. | Conditions: Renal Cell Carcinoma, Metastases | Phase 2 | Status: COMPLETED